Release Date: 05/05/11 08:44 Summary: Appendix 3X - Directors Interest Price Sensitive: No Download Document 10.79KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%